Kumar, E. A., Korfi, K., Bewicke‐Copley, F., Close, K., Heward, J., Witzig, T., . . . Okosun, J. (2024). CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma. British journal of haematology, 205(5), 1804-1809. https://doi.org/10.1111/bjh.19671
Citace podle Chicago (17th ed.)Kumar, Emil Arjun, et al. "CREBBP Histone Acetyltransferase Domain Mutations Predict Response to MTOR Inhibition in Relapsed/refractory Follicular Lymphoma." British Journal of Haematology 205, no. 5 (2024): 1804-1809. https://doi.org/10.1111/bjh.19671.
Citace podle MLA (9th ed.)Kumar, Emil Arjun, et al. "CREBBP Histone Acetyltransferase Domain Mutations Predict Response to MTOR Inhibition in Relapsed/refractory Follicular Lymphoma." British Journal of Haematology, vol. 205, no. 5, 2024, pp. 1804-1809, https://doi.org/10.1111/bjh.19671.